Concepedia

Author

Eliot Godofsky

Bach & Godofsky Infectious Diseases

Also Known As

E. Godofsky, E.W. Godofsky, Eliot Godofsky, Eliot W Godofsky, Eliot W. Godofsky, Paul Pockros, Pradeep Kumar Bekal

47

Publications

1.7K

Citations

21

H-Index

18

Concepts

All Affiliations

Bach & Godofsky Infectious DiseasesLa Roche CollegeJohns Hopkins UniversityOrlando Immunology CenterCornell University
EG

About

Eliot Godofsky is an author at Bach & Godofsky Infectious Diseases specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

439

2

Hepatology

4

4

160

3

Immunology

2

2

80

4

Health Sciences

1

1

28

5

Epidemiology

1

1

59

Eliot Godofsky

×

22

Publications

1.6K

Citations

20

H-Index

YearCitations

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients

Ira M. Jacobson, Robert S. Brown, Bradley Freilich,

Hepatology

2007

306

Antiretroviral Activity of the Anti‐CD4 Monoclonal Antibody TNX‐355 in Patients Infected with HIV Type 1

Daniel R. Kuritzkes, Jeffrey M. Jacobson, William G. Powderly,

The Journal of Infectious Diseases

2004

193

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)

Eric Lawitz, Gary Matusow, Edwin DeJesus,

Hepatology

2015

180

Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults

Jeffrey M. Jacobson, Daniel R. Kuritzkes, Eliot Godofsky,

Antimicrobial Agents and Chemotherapy

2008

160

R1626 plus peginterferon Alfa‐2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin†

Paul J. Pockros, David R. Nelson, Eliot Godofsky,

Hepatology

2008

101

Sinusitis in HIV-infected patients: A clinical and radiographic review

Eliot Godofsky, James Zinreich, Michael Armstrong,

The American Journal of Medicine

1992

91

Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy

Eric Lawitz, Eliot Godofsky, Thomas Marbury,

Antiviral Research

2011

73

Use of Cerebrospinal Fluid Shunts in Patients Having Acquired Immunodeficiency Syndrome with Cryptococcal Meningitis and Uncontrollable Intracranial Hypertension

Michael C. Bach, Philip W. Tally, Eliot Godofsky

Neurosurgery

1997

59

LP04 : A phase 3, open-label, single-arm study to evaluate the efficacy and safety of 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naïve or -experienced patients with chronic HCV genotype 1 infection and cirrhosis: Optimist-2

Eric Lawitz, Gary Matusow, E DeJesus,

Journal of Hepatology

2015

59

Baseline factors prognostic of sustained virological response in patients with HIV–hepatitis C virus co-infection

Gregory J. Dore, Francesca J. Torriani, M. Rodríguez‐Torres,

AIDS

2007

41

Page 1